Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000222621

Medchemexpress LLC Zedoresertib (Debio 0123) | 2243882-74-6 | 99.5% | 511.45 | C26H28Cl2N6O | 5 MG
SDP

Catalog No. 5000222621
Encompass_Preferred

Zedoresertib (Debio 0123) is a potent, selective WEE1 kinase inhibitor used in preclinical research on cell-cycle regulation and DNA damage response. Supplied as a solid or as a DMSO solution, the compound is characterized by high purity and defined physicochemical properties to support reproducible laboratory experiments.

  • Potent WEE1 kinase inhibitor (IC50 0.8 nM).
  • High recommended purity of 99.46%.
  • Available as a solid and as a 10 mM solution in DMSO.
  • Molecular weight 511.45 and formula C26H28Cl2N6O.
  • Intended for cell-cycle and DNA damage response studies.
  • Includes product datasheet and SDS for handling and safety information.

Catalog No. 50-002-22621 Supplier Medchemexpress LLC Supplier No. HY1470545MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Zedoresertib (Debio 0123) is a potent, selective WEE1 kinase inhibitor used in preclinical research on cell-cycle regulation and DNA damage response. Supplied as a solid or as a DMSO solution, the compound is characterized by high purity and defined physicochemical properties to support reproducible laboratory experiments.

  • Potent WEE1 kinase inhibitor (IC50 0.8 nM).
  • High recommended purity of 99.46%.
  • Available as a solid and as a 10 mM solution in DMSO.
  • Molecular weight 511.45 and formula C26H28Cl2N6O.
  • Intended for cell-cycle and DNA damage response studies.
  • Includes product datasheet and SDS for handling and safety information.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.